LynnMSchuchterMD

Hematologic Oncology, Melanoma

Professor of Medicine, University Pennsylvania

Dr. Schuchter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Lynn Schuchter is an oncologist in Haverford, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, and UPMC Presbyterian. She received her medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 35 years. She specializes in hematologic oncology and melanoma and is experienced in sarcomas, melanoma and cutaneous malignancies, and general medical oncology.

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1986 - 1989
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1985 - 1986
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1984
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1982

America's Top Doctors Castle Connolly, 2008-2014
Philadelphia Magazine Castle Connolly, 2005-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FASCO) American Society of Clinical Oncologists, 2008
Super Doctor SuperDoctors.com
Join now to see all

PubMed

Journal Articles

Effect of Integrating Machine Learning Mortality Estimates with Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients with Cancer
Ravi B Parikh, Justin E Bekelman, Lynn M Schuchter, Lawrence N Shulman, Mitesh S Patel, JAMA Oncology
Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients with Cancer
Lawrence N Shulman, Lynn M Schuchter, Mitesh S Patel, Ravi B Parikh, JAMA Oncology
Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 Response
Xiaowei Xu, Haidong Dong, Tara C Mitchell, Lynn M Schuchter, Alexander C Huang, Suzanne McGettigan, Wei Xu, Giorgos C Karakousis, Xiaoming Liu, Gordon Mills, Nature
Timing of Onset of Adverse Cutaneous Reactions Associated with Programmed Cell Death Protein 1 Inhibitor Therapy
Tara C Mitchell, Michael E Ming, Leo L Wang, Suzanne McGettigan, Emily Y Chu, Lynn Schuchter, JAMA
Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
Austin D Williams, Amy S Clark, Paul J Zhang, Julia Tchou, Bruce L Levine, Jennifer M Matro, Laurence J Cooper, Alycia So, Lynn M Schuchter, Carl H June, Angela M DeMi..., Clinical Cancer Research
Join now to see all

Easing Patient Fears of Radiation Treatment, via Virtual RealityOctober 24th, 2024
Improving Care for Patients with Acute Lymphocytic LeukemiaJuly 30th, 2024
OncLive — OncLive Honors 15 Cancer Care PioneersJuly 2nd, 2024
Join now to see all

Cellular Molecular Biologics In Clinical Cancer ResearchNational Cancer Institute2010–2011
Targeted Therapy For MelanomaNational Cancer Institute2004–2008
Targeted Therapy For MelanomaNational Cancer Institute2007
Upcc #1698 Injections Of B7 1 In Patients W/ Metastatic MelanomaNational Center For Research Resources1999–2002
Core--Clinical Research UnitNational Cancer Institute1996–2002
Clinical Application Of Adenovirus-Transduced, B7-Expressing Breast Cancer CellsNational Cancer Institute1996–1998
Phase II Study Of Bryostatin-1 In Patients With Metastatic MelanomaNational Center For Research Resources1996–1997
Genetically-Engineered Vaccine For Melanoma PatientsNational Cancer Institute1995–1997
Phase I Trial Of Ethyol And G-CSF With Dose Escalation Of Taxol In PatientsNational Center For Research Resources1996
Evaluation Of Interleukin-4 Therapeutic And Biological ENational Cancer Institute1990